Literature DB >> 12584192

Fes tyrosine kinase promotes survival and terminal granulocyte differentiation of factor-dependent myeloid progenitors (32D) and activates lineage-specific transcription factors.

Jynho Kim1, Yoshiyasu Ogata, Ricardo A Feldman.   

Abstract

The c-fps/fes proto-oncogene encodes a 92-kDa protein-tyrosine kinase that is involved in myeloid cell development and function. We have recently shown that expression of an activated allele of Fes (Fes(act)) in monocyte precursors resulted in their differentiation into functional macrophages through the activation of lineage-specific transcription factors. We now report that this kinase also plays a role in the survival and terminal differentiation of granulocyte progenitors. The expression of Fes(act) in factor-dependent 32D cells prevented their apoptotic death after interleukin-3 removal, but Fes(act)-expressing cells remained factor-dependent for proliferation. Removal of interleukin-3 from the Fes(act)-expressing cells was followed by granulocytic differentiation in the absence of granulocyte colony-stimulating factor within 4-8 days. The differentiated cells had distinctive granulocyte morphology and there was up-regulation of CD11b, Gr-1, and late differentiation markers such as lactoferrin, suggesting that this kinase induced terminal granulocytic differentiation. Concomitantly, Fes(act) down-regulated the macrophage marker F4/80, suggesting that the biological activity of Fes was coordinated in a lineage-specific manner. Further analysis showed that Fes(act) caused activation of CCAAT/enhancer-binding protein-alpha and STAT3, two transcription factors that are involved in granulocyte differentiation. Our results provide evidence that Fes may be a key component of the granulocyte differentiation machinery, and suggest a potential mechanism by which this kinase may regulate granulocyte-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584192     DOI: 10.1074/jbc.M212118200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

2.  Point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and effects a transformation-like phenotype.

Authors:  Diana Vradii; Sayyed K Zaidi; Jane B Lian; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

3.  Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; William C Grunwald; David Cool; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

4.  Electroporation-mediated delivery of the FER gene in the resolution of trauma-related fatal pneumonia.

Authors:  V A Dolgachev; R Goldberg; M V Suresh; B Thomas; N Talarico; M R Hemmila; K Raghavendran; D Machado-Aranda
Journal:  Gene Ther       Date:  2016-07-22       Impact factor: 5.250

5.  Electroporation-mediated delivery of FER gene enhances innate immune response and improves survival in a murine model of pneumonia.

Authors:  Vladislav Dolgachev; Sreehari Panicker; Sanjay Balijepalli; Lane Kelly McCandless; Yue Yin; Samantha Swamy; M V Suresh; Matthew J Delano; Mark R Hemmila; Krishnan Raghavendran; David Machado-Aranda
Journal:  Gene Ther       Date:  2018-06-15       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.